TAM
AMGN icon

Third Avenue Management’s Amgen AMGN Stock Holding History

Third Avenue Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-216,733
Closed -$37.7M – 80
2017
Q4 		$37.7M Buy
216,733
+6,609
+3% +$1.17M 1.81% 19
2017
Q3 		$39.2M Sell
210,124
-306
-0.1% -$54.2K 1.77% 16
2017
Q2 		$36.2M Sell
210,430
-654
-0.3% -$106K 1.61% 17
2017
Q1 		$34.6M Buy
211,084
+822
+0.4% +$137K 1.58% 18
2016
Q4 		$30.7M Buy
210,262
+76,036
+57% +$11.4M 1.39% 21
2016
Q3 		$22.4M Sell
134,226
-1,416
-1% -$239K 1.03% 32
2016
Q2 		$20.6M Buy
+135,642
New +$21.1M 0.92% 32

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Third Avenue Management's AMGN Position: Q1 2018 in Review

Third Avenue Management sold out of Amgen (AMGN) in Q1 2018, closing a stake of 216,733 shares — an estimated $37.7M sold.

Third Avenue Management first reported a position in AMGN in Q2 2016 and held it in 7 quarters. The position peaked at $39.2M in Q3 2017. 1,750 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Third Avenue Management reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Third Avenue Management sold 216,733 Amgen shares in Q1 2018, an estimated $37.7M.
  • Third Avenue Management first reported a position in Amgen in Q2 2016 and held it in 7 quarters.
  • Third Avenue Management's Amgen position peaked at $39.2M in Q3 2017.
  • 1,750 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Third Avenue Management's 13F filing for Q1 2018, filed 14 May 2018.